Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective blockade of PTH activity by stapled peptide ATSP-10814

Sep. 19, 2014

Empagliflozin/linagliptin FDC shows superior efficacy to individual components

Sep. 18, 2014

Alnylam Pharmaceuticals describes siRNA for treating pre-eclampsia

Sep. 18, 2014

In vitro and in vivo bone anabolic effects of P2X7 receptor blocker AFC-5261

Sep. 18, 2014

Novel potent inhibitors of histone demethylase KDM1A for epigenetic-related cancer therapy

Sep. 18, 2014

ASP-2397, a natural product with potent fungicidal activity

Sep. 18, 2014

Long-term treatment with fingolimod sustains low rates of brain volume loss in LONGTERMS trial

Sep. 18, 2014

Development of non-viral minicircle DNA vectors for phenylketonuria gene therapy

Sep. 18, 2014

RADIANCE results demonstrate RPC-1063 is a promising candidate for relapsing MS

Sep. 17, 2014

Results for the follow-up portion of phase II study evaluating blosozumab

Sep. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...